A Study to Evaluate the Use of SOMVC001 (GALA) Vascular Conduit Preservation Solution in Patients Undergoing CABG (STEPS)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT02272582

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02272582
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02272582. Randomized; quadruple masking; primary purpose prevention. Start 2014-09-24 (actual); primary completion 2016-12-22 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Evaluate the Use of SOMVC001 (GALA) Vascular Conduit Preservation Solution in Patients Undergoing CABG (STEPS)
Acronym
GALA
Intervention (Device)
SOMVC001 Vascular Conduit Solution
Intervention (Other)
Standard of care Heparin-dosed saline
Lead sponsor
Perrault Louis P. (class: other)
Collaborator
Montreal Heart Institute (class: other)
Collaborator
Somahlution LLC (class: industry)

Record details

Record id
cardio:ct-nct02272582
Content hash
a1743349d5da0e811ba4e40b432897736a4af7d4de0c53727cfbab29a5288125